drugset / Trial / NCT06520514
A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial is to investigate the safety and tolerability of a single dose of spesolimab administered in 2 different ways in healthy subjects.
Timeline
- Start
- 2024-08-07
- Primary completion
- 2025-01-15
- Completion
- 2025-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spesolimab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.